Cargando…
Update in the treatment of extracranial atherosclerotic disease for stroke prevention
Stroke is a leading cause of adult mortality and disability worldwide. Extracranial atherosclerotic disease (ECAD), primarily, carotid artery stenosis, accounts for approximately 18%–25% of ischaemic stroke. Recent advances in neuroimaging, medical therapy and interventional management have led to A...
Autores principales: | Zhu, Zhu, Yu, Wengui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213501/ https://www.ncbi.nlm.nih.gov/pubmed/32411410 http://dx.doi.org/10.1136/svn-2019-000261 |
Ejemplares similares
-
Update in the treatment of intracranial atherosclerotic disease
por: Barnard, Zachary R, et al.
Publicado: (2019) -
Associations of neutrophil-to-lymphocyte ratio with intracranial and extracranial atherosclerotic stenosis
por: Xie, Yu, et al.
Publicado: (2022) -
Associations of Monocytes and the Monocyte/High-Density Lipoprotein Ratio With Extracranial and Intracranial Atherosclerotic Stenosis
por: Liu, Zhu, et al.
Publicado: (2021) -
Association between Plasma Adipocytokines Levels and Intracranial versus Extracranial Atherosclerotic among Chinese Patients with Stroke
por: LIU, Chunyu, et al.
Publicado: (2020) -
Current smoking is associated with extracranial carotid atherosclerotic stenosis but not with intracranial large artery disease
por: Ji, Ruijun, et al.
Publicado: (2017)